Table of Contents:
- Cancer incidence in Belgium, 2004-2017
- Pancreatic cancer: Where are we now and where are we going?
- Systemic treatment landscape and algorithm for hormone-receptor positive, HER2 negative advanced breast cancer
- Neoadjuvant treatment considerations in HER2-positive breast cancer patients
- Tissue is the issue
- Succinate dehydrogenase B deficient renal cell carcinoma in a young adult with paraganglioma: Management of a rare, hereditary malignancy
- Optimisation of the liquid biopsy workflow: From research to clinical practice
- New oncology reimbursements in Belgium
